药根碱
巴马汀
小檗碱
传统医学
肾
药理学
医学
化学
内科学
作者
Shaobo Liu,Shengwen Lu,Hui Sun,Aihua Zhang,Hui Wang,Wenfeng Wei,Jin-run Han,Ya‐Jing Guo,Xijun Wang
出处
期刊:Phytomedicine
[Elsevier]
日期:2021-10-01
卷期号:91: 153690-153690
被引量:18
标识
DOI:10.1016/j.phymed.2021.153690
摘要
Cortex Phellodendri amurensis (CPA) has high medicinal value in the treatment of kidney-yin deficiency diseases. However, due to the lack of research on the therapeutic material basis of CPA, the current quality control standard for CPA is defective, and the effect of the nourishing kidney-yin of CPA was limited. Based on the principle of correspondence between the syndrome and prescriptions, we studied the CPA in ZhibaiDihuang pill (ZBDH) to identify quality markers (Q-markers) of CPA in ZBDH for treating kidney-yin deficiency and seek the potential Q-markers of CPA under nourishing kidney-yin effect combined with the analysis of single CPA. Taking Chinmedomics as the core strategy, metabonomics analysis and effective component identification were performed by UPLC-MS. A total of 121 chemical components of ZBDH were identified, among which the contents of berberine, palmatine, jatrorrhizine and magnoflorine changed the most obviously with the addition of CPA. Forty-five components were identified in the blood in the markedly effective state, including berberine, palmatine, jatrorrhizine and magnoflorine. The therapeutic material basis of ZBDH in the treatment of kidney-yin deficiency was found, and 6 components were found to derive from CPA, including magnoflorine and jatrorrhizine. In addition, seventeen components were identified in the blood in the single CPA treatment, including berberine, palmatine, jatrorrhizine and magnoflorine. Magnoflorine and jatrorrhizine were the Q-markers of CPA for treating kidney-yin deficiency in the formula of ZBDH and they were also potential Q-markers of the nourishing kidney-yin of CPA.
科研通智能强力驱动
Strongly Powered by AbleSci AI